The tweet was deleted by the author.
But we saved everything 🙂.
Zymeworks announced the upcoming presentations by two of its senior researchers at the ESMO Targeted Anticancer Therapies Congress in Paris from March 16 to 19.
Nina E. Weisser, Senior Director of Multispecific Antibody Therapeutics, and Raffaele Colombo, Associate Director of Medicinal Chemistry, will offer insights into the development of multispecific antibody therapies. Colombo will specifically present on the path to antibody drug conjugate (ADC) discovery, underscoring the company’s emphasis on innovative oncology solutions.